Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancerVOKES, Everett E; STENSON, Kerstin; MITTAL, Bharat B et al.Journal of clinical oncology. 2003, Vol 21, Num 2, pp 320-326, issn 0732-183X, 7 p.Article

Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapyARGIRIS, Athanassios; BROCKSTEIN, Bruce E; HARAF, Daniel J et al.Clinical cancer research. 2004, Vol 10, Num 6, pp 1956-1962, issn 1078-0432, 7 p.Article

Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancerHARAF, Daniel J; ROSEN, Fred R; WEICHSELBAUM, Ralph R et al.Clinical cancer research. 2003, Vol 9, Num 16, pp 5936-5943, issn 1078-0432, 8 p., 1Article

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancerARGIRIS, Athanassios; STENSON, Kerstin M; HARAF, Daniel J et al.Head & neck. 2004, Vol 26, Num 5, pp 447-455, issn 1043-3074, 9 p.Article

Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancerROSEN, Fred R; HARAF, Daniel J; PELZER, Harold et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1689-1697, issn 1078-0432, 9 p.Article